Dexaguard 0.1%+0.5% (Ophthalmic Solution)
5 ml drop: ৳ 70.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Dexamethasone chloramphenicol |
| Company | Incepta pharmaceuticals ltd |
Indications
- acute purulent conjunctivitis
- fresh inflammation of the superficial and deeper corneal layers
- corneal ulceration
- keratitis disciformis
- post-herpetic keratitis
- allergic conjunctivitis
- allergic blepharitis
- acute iritis
- chronic iritis
- chronic anterior uveitis
- corneal injury from chemical radiation or thermal burns
- penetration of foreign bodies
- otitis externa
- otitis media
- chronic suppurative otitis media
Pharmacology
- glucocorticoid
- anti-inflammatory action
- anti-allergic action
- topical treatment
- rapid absorption
- broad spectrum bacteriostatic antibiotic
- inhibition of bacterial protein synthesis
Dosage & Administration
- recommended dosage regimen for bacterial conjunctivitis
- recommended dosage regimen for corneal ulcers
- recommended dosage regimen for otitis externa
- frequency adjustment based on clinical signs
Interaction
- increased effect when taken with anticoagulants
- inhibition with Phenobarbital
- reduced efficacy with phenytoin, phenobarbitone, ephedrine, rifampicin
Contraindications
- epithelial herpes simplex cornealis
- fungal, viral, tuberculous and other infections of the eye
- glaucoma
- myelosuppression during previous exposure to Chloramphenicol
- hypersensitivity to Chloramphenicol & Dexamethasone Phosphate or any other ingredients
Side Effects
- transient ocular burning
- ocular discomfort
- stinging
- redness
- itching
- conjunctivitis
- foreign body sensation
- photophobia
- blurred vision
- dryness
- eye pain
- allergic sensitization
- elevation of intraocular pressure
- possible development of glaucoma
- optic nerve damage
- posterior subcapsular cataract formation
Pregnancy & Lactation
- potential benefit justifies potential risk to the fetus
- caution when administered to nursing mothers
Precautions & Warnings
- persistent fungal infections of the cornea
- posterior subcapsular cataract formation
- glaucoma with optic nerve damage
- intraocular pressure monitoring
- overgrowth of non-susceptible organisms
- discontinuation and alternative therapy if new infections appear
Therapeutic Class
- ophthalmic steroid - antibiotic combined preparations
Storage Conditions
- cool and dry place
- away from light
- keep out of the reach of children
- do not use after 30 days of first opening
Related Brands
- Stedex-C 0.1%+0.5% (Ophthalmic Solution) - navana-pharmaceuticals-ltd
- Eyephen Plus 0.1%+0.5% (Ophthalmic Solution) - healthcare-pharmaceuticals-ltd
- Chlormet 0.1%+0.5% (Ophthalmic Solution) - beximco-pharmaceuticals-ltd
- Stenicol 0.1%+0.5% (Ophthalmic Solution) - drug-international-ltd
- Sonexa-C 0.1%+0.5% (Ophthalmic Solution) - aristopharma-ltd